Skip to main content
. 2018 Oct 2;18(2):142–149. doi: 10.2463/mrms.mp.2017-0157

Fig. 2.

Fig. 2.

A tumor-bearing C57BL/6 mouse in which EL-4 cells were injected subcutaneously in its flank 2 weeks ago.